From having grinding sensations in the hip joint to experiencing pain the hip and groin, here are the early signs of hip ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

A study of more than 6 million children finds that exposure to antibiotics in the womb or early in life tends not to increase ...

GLP-1s aren't FDA-approved to treat rheumatoid arthritis, but many people notice improvement in their inflammation with the ...

A new German study has found a modest increase in cancer risk among rheumatoid arthritis (RA) patients treated with Janus kinase inhibitors (JAKis) compared to those receiving biologic ...

Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. AbbVie is currently recruiting participants for a ...

Medicare enrollees who buy the optional Part D drug benefit may see substantial premium price hikes — potentially up to $50 a ...

JAK inhibitors for rheumatoid arthritis demonstrate higher risks for cancer vs. biologic disease-modifying antirheumatic drugs, particularly among older patients and those with higher disease activity ...

An increasing trend of continuous TNF inhibitor use is seen among pregnant women with chronic inflammatory diseases, with associated reduced corticosteroid us ...

Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by the formation of an invasive and proliferative ...

Power Doppler ultrasound may help predict rheumatoid arthritis treatment response, though its role in forecasting remission ...